title: Tamoxifen and the uterus and endometrium.
authors.forename: A
authors.initials: A
authors.lastname: Cano
authors.forename: P
authors.initials: P
authors.lastname: Matallin
authors.forename: V
authors.initials: V
authors.lastname: Legua
authors.forename: M
authors.initials: M
authors.lastname: Tortajada
authors.forename: F
authors.initials: F
authors.lastname: Bonilla-Musoles
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D004715:Endometriosis / Q000139:chemically induced* / Q000188:drug therapy; D004717:Endometrium / Q000187:drug effects; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000139:chemically induced*; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen